Insight

Peter Adams: Aged tissues at increased risk of cancer due to “precarious balance”

Photo of Peter Adams from sbpdiscovery.org

Aug 8, 2024, 05:38

Peter Adams: Aged tissues at increased risk of cancer due to “precarious balance”

Peter Adams, Director of NCI-designated Cancer Genome and Epigenetics Program at Sanford Burnham Prebys (SBP), shared on X a recent paper by Aaron Havas et al. titled “Activated Interferon Signaling Suppresses Age-Dependent Liver Cancer” published in BioRxiv.

Authors: Aaron Havas, Kathryn Lande, Adarsh Rajesh, Garrett Evensen, Siva Karthik Varanasi, Linshan Shang, Elizabeth Schmidt, Jin Lee, Kenneth Kim, ProfileMarcos Garcia Teneche, Filipe Hoffmann, Peter Adams et al.

Peter Adams

“New study led by talented post doc in the lab Aaron Havas:

aged tissues at increased risk of cancer due to ‘precarious balance’.
age-activated IFN signaling is an adaptive response to prevent cancer in older tissues, but with maladaptive consequence.”

Peter Adams

Source: Peter Adams/X

Aaron Havas Adarsh Rajesh Aging Biology Journal cancer Elizabeth Schmidt Filipe Hoffmann Garrett Evensen IFN Jin Lee Kathryn Lande Kenneth Kim Linshan Shang Michael LaPorte OncoDaily Oncology Peter Adams ProfileMarcos Garcia Teneche Sanford Burnham Prebys Siva Karthik Varanasi

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Special Coverage